Table 3. Influence of six factors on recurrence-free survival in a Cox multivariable model in the SSGXVIII/AIO series.
| Variable | Hazard ratio (95% CI) | P |
|---|---|---|
| Tumour mitotic count | 1.03 (1.02–1.03) | <0.001 |
| As a continuous variable | ||
| Tumour site | 3.03 (2.05–4.46) | <0.001 |
| Non-gastric vs gastric | ||
| Duration of adjuvant imatinib | 2.22 (1.52–3.22) | <0.001 |
| 1 year vs 3 years | ||
| Tumour rupture | 2.25 (1.52–3.33) | <0.001 |
| Present vs absent | ||
| Tumour size | 1.05 (1.02–1.07) | 0.001 |
| As a continuous variable | ||
| Tumour SLUG expression | 1.63 (1.13–2.36) | 0.009 |
| Present vs absent |
Abbreviation: CI, confidence interval.